The markets opened lower with the Dow losing 16 points to 12,636 ahead of the release of minutes from the Federal Reserve's meeting. Nasdaq eased a point to 2901. On the upside
Orexigen Therapeutics (Nasdaq: OREX) announced that enrollment for its Contrave cardiovascular clinical trial was much quicker than expected. VeriFone Systems (NYSE: PAY) won a five-year $35 million contract to install and support driver and passenger information and payment systems in 6,500 taxi cabs in Washington, D.C. A Seeking Alpha contributor wrote that Nokia (NYSE: NOK) had much upside potential. On the downside First quarter losses for OCZ Technology (Nasdaq: OCZ) was larger than expected as expenses surged. Prospect Capital (Nasdaq: PSEC) priced its public offering of 21 million common shares at the discounted price of $11.15 per share. Goldcorp (NYSE: CMI) cut its production guidance for 2012. In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks edged up a point to 796.